ARAY

MKT CAP:$54M

Accuray Incorporated

Market Cap

$54M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$0.45-$0.40 (-46.63%)

Apr 23, 2026

Company Details

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Afri...

CEO

Ali Pervaiz

IPO Date

Feb 8, 2007

Website

www.accuray.com

Key Metrics TTM

Revenue

$437M

-3.6% YoY

Net Income

-$36M

EPS (Diluted)

-$0.29

Free Cash Flow

-$6M

Revenue / Share

$3.64

Gross Margin

27.7%

Operating Margin

-2.6%

Net Margin

-8.2%

FCF Margin

-1.4%

P/S

0.1x

P/E

—

Earnings Reports

Q3 2026

Apr 29, 2026

PENDING

Q2 2026

Feb 17, 2026

$102M-12.0%EPS -$0.11

Q1 2026

Nov 5, 2025

$94M-7.5%EPS -$0.18

FY 2025

Aug 28, 2025

$459M+2.7%EPS -$0.02

Q4 2025

Aug 28, 2025

$128M-5.0%EPS $0.01

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 22	$96M	$35M	-$292.0K
Q4 22	$110M	$43M	$2M
Q1 23	$96M	$35M	-$2M
Q2 23	$115M	$43M	$3M
Q3 23	$118M	$39M	$2M
Q4 23	$118M	$38M	-$457.0K
Q1 24	$104M	$39M	$2M
Q2 24	$107M	$36M	-$4M
Q3 24	$101M	$29M	-$5M
Q4 24	$134M	$38M	$7M
Q1 25	$102M	$34M	-$2M
Q2 25	$116M	$42M	$5M
Q3 25	$113M	$32M	$1M
Q4 25	$128M	$39M	$4M
Q1 26	$94M	$27M	-$11M
Q2 26	$102M	$24M	-$5M

Valuation

Quarter	P/S	P/E
Q3 22	0.1x	—
Q4 22	0.1x	—
Q1 23	0.1x	—
Q2 23	0.1x	—
Q3 23	0.1x	—
Q4 23	0.1x	—
Q1 24	0.1x	—
Q2 24	0.1x	—
Q3 24	0.1x	—
Q4 24	0.1x	—
Q1 25	0.1x	—
Q2 25	0.1x	—
Q3 25	0.1x	80.7x
Q4 25	0.1x	—
Q1 26	0.1x	—
Q2 26	0.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 22	-$22M	-$23M
Q4 22	-$5M	-$6M
Q1 23	$46.0K	-$1M
Q2 23	-$18M	-$20M
Q3 23	$25M	$23M
Q4 23	$9M	$846.0K
Q1 24	-$9M	-$10M
Q2 24	-$5M	-$6M
Q3 24	-$8M	-$9M
Q4 24	$10M	$9M
Q1 25	-$7M	-$8M
Q2 25	$2M	$927.0K
Q3 25	$18M	$16M
Q4 25	-$10M	-$13M
Q1 26	$12M	$8M
Q2 26	-$16M	-$17M

Capital Expenditures

Quarter	CapEx
Q3 22	$1M
Q4 22	$1M
Q1 23	$1M
Q2 23	$2M
Q3 23	$2M
Q4 23	$8M
Q1 24	$1M
Q2 24	$1M
Q3 24	$795.0K
Q4 24	$465.0K
Q1 25	$1M
Q2 25	$874.0K
Q3 25	$2M
Q4 25	$3M
Q1 26	$4M
Q2 26	$1M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 22	-6.2%	-1.7%
Q4 22	-0.8%	+1.1%
Q1 23	-10.2%	-6.1%
Q2 23	-1.3%	-0.2%
Q3 23	+22.8%	+20.0%
Q4 23	+7.5%	+10.0%
Q1 24	+7.7%	+3.0%
Q2 24	-6.6%	-0.8%
Q3 24	-14.3%	-8.7%
Q4 24	+13.5%	+7.3%
Q1 25	-2.3%	+2.0%
Q2 25	+8.3%	+0.2%
Q3 25	+12.0%	+6.2%
Q4 25	-5.0%	-3.3%
Q1 26	-7.5%	+1.5%
Q2 26	-12.0%	-3.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 22	$3M	2.8%
Q4 22	$0	0.0%
Q1 23	$3M	3.0%
Q2 23	$3M	2.7%
Q3 23	$2M	1.3%
Q4 23	$0	0.0%
Q1 24	$2M	2.3%
Q2 24	$2M	2.2%
Q3 24	$3M	2.7%
Q4 24	$2M	1.5%
Q1 25	$2M	2.3%
Q2 25	$2M	2.0%
Q3 25	$3M	2.4%
Q4 25	$3M	2.2%
Q1 26	$3M	2.7%
Q2 26	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q3 22	$14M	$10M	$11M
Q4 22	$15M	$12M	$14M
Q1 23	$14M	$12M	$11M
Q2 23	$15M	$12M	$14M
Q3 23	$14M	$11M	$11M
Q4 23	$14M	$13M	$11M
Q1 24	$14M	$13M	$10M
Q2 24	$15M	$13M	$11M
Q3 24	$11M	$12M	$10M
Q4 24	$10M	$11M	$11M
Q1 25	$12M	$13M	$12M
Q2 25	$14M	$12M	$11M
Q3 25	$11M	$11M	$9M
Q4 25	$11M	$12M	$11M
Q1 26	$11M	$15M	$12M
Q2 26	$11M	$10M	$9M

Revenue Segments

Quarter	Product	Service
Q1 24	$53M	$51M
Q2 24	$52M	$56M
Q3 24	$50M	$52M
Q4 24	$80M	$55M
Q1 25	$48M	$53M
Q2 25	$61M	$55M
Q3 25	$57M	$56M
Q4 25	$71M	$57M
Q1 26	$37M	$57M
Q2 26	$45M	$57M

Revenue by Geography

Quarter	Americas	Asia Pacific Excluding Japan And China	China	Europe India Middle East And Africa	Japan	Asia Pacific Excluding China	Asia Pacific	Eimea
Q3 22	$25M	$9M	$21M	$30M	$12M	—	—	—
Q1 23	$27M	$8M	$11M	$37M	$13M	—	—	—
Q2 23	$28M	$9M	$22M	$40M	$16M	—	—	—
Q3 23	$34M	$7M	$22M	$38M	$17M	—	—	—
Q4 23	$33M	$7M	$20M	$41M	$17M	—	—	—
Q1 24	$21M	$5M	$26M	$40M	$13M	—	—	—
Q2 24	$24M	—	$23M	$44M	$11M	$6M	—	—
Q3 24	$21M	—	$19M	$38M	$15M	$8M	—	—
Q4 24	$25M	—	$35M	$47M	$17M	$15M	—	—
Q1 25	$21M	—	$34M	$26M	$10M	$11M	—	—
Q2 25	$17M	—	$36M	$39M	$15M	$9M	—	—
Q3 25	$20M	—	$24M	$40M	$13M	—	$15M	—
Q1 26	$25M	—	$15M	$34M	$9M	—	$10M	—
Q2 26	$17M	—	$18M	—	$11M	—	$13M	$43M

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$98M	$0	$98M
Q4 22	$89M	$0	$89M
Q1 23	$81M	$0	$81M
Q2 23	$68M	$0	$68M
Q3 23	$89M	$0	$89M
Q4 23	$89M	$0	$89M
Q1 24	$77M	$0	$77M
Q2 24	$73M	$0	$73M
Q3 24	$60M	$0	$60M
Q4 24	$69M	$0	$69M
Q1 25	$59M	$0	$59M
Q2 25	$63M	$0	$63M
Q3 25	$78M	$0	$78M
Q4 25	$57M	$0	$57M
Q1 26	$64M	$0	$64M
Q2 26	$41M	$0	$41M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 22	93M	-1.2%	-0.4%
Q4 22	93M	+0.3%	+1.6%
Q1 23	94M	+0.5%	+3.0%
Q2 23	95M	+1.1%	+0.7%
Q3 23	97M	+3.1%	+5.1%
Q4 23	96M	-1.5%	+3.1%
Q1 24	97M	+0.6%	+3.2%
Q2 24	98M	+1.3%	+3.4%
Q3 24	99M	+1.5%	+1.8%
Q4 24	101M	+1.8%	+5.3%
Q1 25	100M	-0.8%	+3.8%
Q2 25	104M	+3.5%	+6.1%
Q3 25	103M	-0.9%	+3.7%
Q4 25	109M	+5.9%	+7.8%
Q1 26	119M	+9.2%	+18.7%
Q2 26	120M	+0.9%	+15.6%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 22	$96.7K	995
Q4 22	$105.4K	1K
Q1 23	$92.4K	1K
Q2 23	$109.9K	1K
Q3 23	$113.1K	1K
Q4 23	$115.5K	1K
Q1 24	$101.5K	1K
Q2 24	$104.7K	1K
Q3 24	$98.8K	1K
Q4 24	$136.1K	987
Q1 25	$102.9K	987
Q2 25	$117.7K	987
Q3 25	$114.7K	987
Q4 25	$128.8K	990
Q1 26	$94.9K	990
Q2 26	$103.3K	990

Revenue / Employee